Distributed in North China, Northwest China, Heilongjiang, Jilin, Taiwan Province, Guangdong, Sichuan, Yunnan, Tibet and other places. It has the effects of promoting blood circulation, stopping bleeding, dissolving drinks and stopping diarrhea. Commonly used for bloody collapse, bloody stranguria, proctoptosis, bleeding, leukorrhagia, amenorrhea, abdominal mass accumulation, drinking addiction and diarrhea due to spleen deficiency.
pharmacological action
1, inhibition of sweat gland secretion;
2. Digitalis-like effect; Low concentration can excite smooth muscle, while high dose can inhibit it;
3. The toxic dose can cause the motor center and respiratory center of the delayed cerebral artery to be excited first and then paralyzed;
4, anti-tumor, anti-cancer, anti-fibrosis, anti-oxidation and analgesic effects;
5, antibacterial effect;
6. Immune regulation.
Extended data:
Use history
The earliest medical record of Phellinus igniarius can be traced back to Shennong Materia Medica in the Eastern Han Dynasty, when it was recorded as "mulberry ear". It was mentioned that Phellinus igniarius had anti-inflammatory, hemostatic and gynecological effects. The name of Phellinus linteus first appeared in Tang Zhenquan's Theory of Medicinal Properties, and Li Shizhen's Compendium of Materia Medica in the Ming Dynasty also mentioned related records.
At the end of World War II, Hiroshima and Nagasaki in Japan were attacked by atomic bombs, and the proportion of cancer increased. However, after taking Phellinus igniarius, the residents who moved to Nudao had a lower proportion of cancer.
1968, Japanese scholars found that Phellinus linteus has obvious anticancer effect in animal experiments. South Korea also supported the study of Phellinus linteus in 1984, and approved Phellinus linteus mycelium as an anticancer drug in 1997.
References:
Baidu encyclopedia-Phellinus igniarius